SUTRO BIOPHARMA, INC. Employee Count
The employee counts SUTRO BIOPHARMA, INC. states in its annual reports on SEC EDGAR, each as filed.
- 2025-12-31: Employees (as filed) 137; Filing 2026-03-23; Lease expense per employee $80,226.28.
- 2024-12-31: Employees (as filed) 310; Filing 2025-03-13; Lease expense per employee $35,525.81.
- 2023-12-31: Employees (as filed) 302; Filing 2024-03-25; Lease expense per employee $30,993.38.
- 2022-12-31: Employees (as filed) 278; Filing 2023-03-30; Lease expense per employee $28,223.02.
- Available history
- 2018-12-31 to 2025-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2025-12-31 | 137 full-time | 2026-03-23 | $80,226.28 total lease cost |
| 2024-12-31 | 310 full-time | 2025-03-13 | $35,525.81 total lease cost |
| 2023-12-31 | 302 full-time | 2024-03-25 | $30,993.38 total lease cost |
| 2022-12-31 | 278 full-time | 2023-03-30 | $28,223.02 total lease cost |
| 2021-12-31 | 224 full-time | 2022-02-28 | $47,147.32 total lease cost |
| 2020-12-31 | 191 full-time | 2021-03-18 | $24,607.33 rent expense, net |
| 2019-12-31 | 168 full-time | 2020-03-16 | $21,428.57 rent expense, net |
| 2018-12-31 | 147 full-time | 2019-04-01 | $24.49 rent expense, net |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 |